Novo Nordisk remains a dominant business with a strong pipeline, and current multiples are low enough to justify a buy. Read my latest analysis of NVO stock.

FOXBOROUGH – The Patriots are reshaping their running back room, adding a veteran to the practice squad and elevating a younger player. The roster shuffling also comes on a day when Rhamondre ...

Carolina has added a familiar face to its crowded wide receiver room. The Panthers signed wide receiver/special teams ace Dan Chisena to the practice squad on Tuesday, the team announced. In a ...

The Bangalore Metro Rail Corporation Limited (BMRCL) on Thursday announced that a fifth train will be introduced on the Yellow Line from November 1, coinciding with the 70th Karnataka Rajyotsava ...

The 1970s were one of the most volatile decades in recent economic history, giving rise to a commodities boom that saw soybean prices soar, then plummet. Bitcoin’s price chart has started to show ...

SOUTH SAN FRANCISCO, Calif., Oct. 20, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a leading precision medicine oncology company, announced the first reported median overall survival ...

WILMINGTON, Del., October 19, 2025--(BUSINESS WIRE)--Positive results from the TROPION-Breast02 Phase III trial showed DATROWAY ® (datopotamab deruxtecan-dlnk) demonstrated a statistically significant ...

For the last few weeks, we’ve been running a sidebar survey about some of the factors that are convincing Electrek readers to add home solar power systems to their homes. After receiving over a ...

Positive results from the TROPION-Breast02 Phase III trial showed DATROWAY ® (datopotamab deruxtecan-dlnk) demonstrated a statistically significant and clinically meaningful improvement for the dual ...